Published online Nov 25, 2015. doi: 10.5495/wjcid.v5.i4.77
Peer-review started: January 16, 2015
First decision: March 20, 2015
Revised: August 11, 2015
Accepted: September 7, 2015
Article in press: September 8, 2015
Published online: November 25, 2015
Processing time: 316 Days and 0.7 Hours
Core tip: The emergence of highly drug resistant (DR) Mycobacterium tuberculosis and human immunodeficiency virus epidemic has paved the way for resurgence of tuberculosis (TB). Extrapulmonary tuberculosis (EPTB), accounts for a significant proportion of all notified TB cases, is a persistent global health issue. Although DR-EPTB is uncommon, but the increasing rate of DR-pulmonary TB around the world has heightened our concern for DR-EPTB too. Unfortunately, systematic surveillance data on DR-EPTB is lacking, however, sporadic information from different countries has begun to accumulate. Here, we aim to provide current understanding on epidemiological scenario of DR-EPTB and also to address some of the key challenges associated with diagnosis, control and management of DR-EPTB.
